1
Clinical Trials associated with Dendritic cells vaccine(Hospital Clinic of Barcelona)Phase II Study of Autologous Myeloid Dendritic Cells as a "Cellular Adjuvant" for a Therapeutic HIV-1 Vaccine in Early Stage HIV-1+ Patients (DCV-2).
To study the efficacy of a therapeutic HIV vaccine consisting of autologous myeloid dendritic cells pulsed ex vivo with high doses of inactivated autologous HIV-1, in HIV-1 infected patients in a very early stages of the disease (CD4 > 450 x 10 6 /L).
To analyze the HIV-1 humoral and cellular immune responses induced by this immune-based therapy.
100 Clinical Results associated with Dendritic cells vaccine(Hospital Clinic of Barcelona)
100 Translational Medicine associated with Dendritic cells vaccine(Hospital Clinic of Barcelona)
100 Patents (Medical) associated with Dendritic cells vaccine(Hospital Clinic of Barcelona)
100 Deals associated with Dendritic cells vaccine(Hospital Clinic of Barcelona)